Please login to the form below

Not currently logged in
Email:
Password:

Gazyvaro

This page shows the latest Gazyvaro news and features for those working in and with pharma, biotech and healthcare.

NICE backs Roche’s Gazyvaro after initial rejection

NICE backs Roche’s Gazyvaro after initial rejection

NICE backs Roche’ s Gazyvaro after initial rejection. An undisclosed discount swayed the cost-effectiveness body. ... The Scottish Medicines Consortium (SMC) turned down Gazyvaro as a first-line option with chemotherapy last month.

Latest news

More from news
Approximately 12 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...
AZ Campus
AstraZeneca: building a new ‘open innovation’ pharma company
The construction of its new HQ has suffered some serious delays, but new R&D and commercial success are lifting AstraZeneca’s prospects...
Erik Nordkamp
In conversation with Pfizer’s Erik Nordkamp
Pfizer’s UK general manager talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe...

Infographics